Safety and Potency of a High Cabergoline Dosage in Microprolactinomas
Clinical trial NCT07463235 · RECRUITING
Trial details
- NCT number
- NCT07463235
- Sponsor
- University of Sao Paulo General Hospital
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-04
- Primary completion
- 2027-08-20
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.